The Asian Pacific Association for the Study of the Liver [APASL]

Monthly News

Message from the Organizer of APASL STC 2016 in Turkey

Dear Colleagues,

I am honored to invite you to the single topic conference on Non Responders that will be held in Istanbul on 22-24 September 2016. Such problems as the exposure of patients to cirrhosis of the liver, and its complications due to the unresponsiveness of chronic hepatitis B, C, and delta infections, to the current treatments; the development of hepatocellular carcinoma; and recurrence of infections following liver transplantation continue to be challenging issues in today’s world. New research with respect to patients with chronic hepatitis and who do not respond, specifically to the treatments specified in the treatment guidelines, will be presented, and interactive discussions will be held with the world’s opinion leaders on hepatology.

At the same time, the similarities and differences (if any) in terms of treatment between the East and the West will be debated. In particular, the steadily increasing trends in cirrhosis of the liver and hepatocellular cancer rates dependent on the unresponsiveness of the hepatitis C virus, between 2020-2030, will be confronted. For this reason, the treatment of compensated and/or decompensated cirrhosis of the liver being unresponsive or partially responsive to previous treatments or those developing dependent on relapses following treatment will continue to be a globally significant health problem.

Following the discovery of the Neolithic settlement during excavations in Yenikapı (the ancient port of Theodosius) it is now understood that the origins of Istanbul date back at least 8,500 years. The city of Istanbul was known as Byzantium by the Greeks in 700 BCE; as Constantinople it was the capital of the Roman and Eastern Roman Empires. Following the conquest of the city by the Ottoman Empire in 1453, the city remained the capital of the Ottoman Empire for almost five centuries, and was known to the Turks as Istanbul.

Among the most important monuments defining the culture and identity of the city are, the Hippodrome, the Basilica Cistern and the Column of Constantine date, which date from Roman times. Then there is the Galata Tower but by the Genoese, and of course, Haghia Sophia, which still stands as the most important testament to the Byzantine age in the world after 1500 years. Then there are the Ottoman buildings, such as the Topkapı Palace, for centuries the residence of the Ottoman sultans and the administrative center, together with more than 80 museums and 9 other Ottoman palaces. The Sultanahmet Mosque and Süleymaniye Mosque and superb examples of Ottoman religious architecture and the Grand Bazaar and Spice Market (Kapalıçarşı and Mısır Çarşısı), both still going strong today, continue the commercial tradition, for which Istanbul is so famous.

Istanbul’s cultural heritage has given the city international importance: in 2010 it was the European Capital of Culture and it is now included in the UNESCO World Heritage List. With its historical and natural beauties, bridges and underwater tunnel connecting the Asian and European continents, Istanbul shines like pearl on the Bosphorus.

Its ancient history and five centuries as the capital of the Ottoman Empire mean that alongside its own cultural wealth and culinary diversity, Istanbul embraces the illustrious cuisines of Asia, Europe and Africa. Turkish cuisine, now only second to Chinese in terms of popularity, celebrates its huge range of dishes, amazingly there are more than 400 varieties of dessert alone, and all of them are distinctive and delicious.

I would like to conclude by saying how I will be more than pleased to be your host in Istanbul, offering you the finest Traditional Ottoman Hospitality on the occasion of this scientifically rich program.

Kind regards,

  • Prof. A. Kadir DOKMECİ, MD
    Honorary President
  • Prof. Necati ORMECİ, MD
    Congress President
  • Prof. Hasan OZKAN, MD
    Congress Secretary General

APASL STC on Non-Responders in Turkey

Date: September 22-24, 2016
City: Istanbul, Turkey
President: Dr. Necati Ormeci

APASL2017 in Shanghai

Dear Colleagues,

We are delighted and honored to introduce you to the 26th Conference of the Asian Pacific Association for the Study of the Liver (APASL), which will take place at Shanghai International Convention Center, on 16-19 February 2017 in Shanghai, China. We will bring together a distinguished faculty of renowned specialists from Asia Pacific and around the world to this conference.

APASL annual meeting has grown as the leading conference focusing on remarkable progress in liver disease, aimed to provide the latest scientific and evidence-based research result that will be applicable to the everyday clinical practice. It provides an excellent opportunity to share and exchange experiences especially from the view of Asian Pacific countries. These elements are essential to pave a way for better development of Hepatology.

We planned to have a three-day core program to provide an overview of varies liver diseases with the State-of- the Art Lectures on hot-off-the-press issues. Besides, Postgraduate Courses and Morning Sessions will be de- signed for the in-depth discussion on particular topics.

Free paper and poster presentation is always the soul of the conference to share research findings and there will be several awards available for application aimed to support young scientists to attend the conference and encourage scientific research.

We thus enthusiastically invite you to submit abstract and join us in this conference as well as our blooming city – Shanghai.

We look forward to welcoming you in Shanghai!

Prof. Jinlin Hou

President of APASL2017

APASL STC 2016 in Beijing

Dear, Colleagues and Distinguished Guests,

On behalf of the Organizing Committee and Scientific Committee, it is our great pleasure to welcome you to join the APASL STC 2016 – 6thHBV Conference, which will be held on December 16-18, 2016 in Beijing, China.

As an influential and responsible academic association, APASL always promotes research and education in hepatology and focuses on combating liver diseases. The APASL Single Topic Conference (STC) is dedicated to the advancement of liver diseases treatment in Asian-Pacific countries and provide an excellent communication platform for global and regional hepatologists. The theme of this conference is “Enhancing Knowledge for Better Patient Care”. Currently, chronic HBV infection remains a serious public health problem due to its worldwide distribution and potential severe outcomes, particularly in the Asian-Pacific region. In the last two decades, with the effort of researchers and clinicians, great progresses in this field have been made. The most up-to-date findings from the translational medicine to the clinical management of viral hepatitis B infection, including prevention and control, novel targets and drug discovery, biomarkers and diagnosis, and the treatment guidelines will be discussed. The experts will bring their didactic lectures to join together and make this conference an unforgettable academic event.

For APASL, China is a major center for basic and clinical research of liver diseases. We are therefore delighted to host 2016 APASL STC in Beijing., the capital of China and an international hub that connecting China and the world. We believe that extensive discussions and wonderful experience will be shared between Chinese doctors and international colleagues.

Prof. Lai Wei

Congress Chairman APASL STC-6th HBV Conference

APASL STC on HBV in China

Date: December 16-18, 2016
City: Beijing, China
President: Dr. Lai Wei

APASL STC 2017 in Nagasaki

Dear Colleagues,

On behalf of the Organizing Committee, it gives us great pleasure to invite you to the 23rd Asian Pacific Association for the Study of the Liver Single Topic Conference (APASL STC), which will be held on April 10-12, 2017 in Nagasaki, Japan. We are delighted to welcome you to the beautiful, exotic city of Nagasaki in Kyushu Island of Japan.

Under the theme of “Prevention of HCC Development,” the conference program will present high-quality content based on up-to-date information and cutting edge lectures by eminent researchers, in order to reconfirm the achievement of better basic and clinical practice in the field of Prevention of HCC Development.

The scientific program will consist of invited lectures, plenary sessions, symposia, and free papers on significant developments on the theme of Prevention and Management of HCC Development. The program will also provide the latest information and fresh ideas for hepatologists.

The conference will encourages the submission of abstracts on research for oral and poster presentations through the conference website. We would appreciate your submission and anticipate a large number of entries, which will stimulate active discussions.

Approximately 1000 delegates of experts from all over the world are expected to attend this conference. We are sure that this will provide an excellent opportunity for those of us in the Asian Pacific region to share the latest views, values, experience and practice, and greatly contribute to the progress of Prevention of HCC Development.

We are looking forward to welcoming you to Nagasaki in the season when tulips, daffodils and other flowers are in full bloom in a popular park situated just across the street from the conference venue.

With warmest regards,

Hiroshi Yatsuhashi M.D.

President, The 23rd APASL Single Topic Conference in Nagasaki

Director General, Clinical Research Center, National Hospital Organization (NHO) Nagasaki Medical Center

Professor, Department of Hepatology, Nagasaki University Graduate School of Biomedical Sciences

APASL STC on Prevention of HCC development in Japan

Date: April 10-12, 2017
City: Nagasaki, Japan
President: Dr. Hiroshi Yatsuhashi

Future APASL Conferences

APASL STC on HCV and coinfection in Mongolia

Date: To be announced.
City: Ulaanbaatar, Mongolia
President: Dr. Oidov Baatarkhuu

APASL STC on HCV in Cairo, Egypt

Date: September 6-8, 2017
City: Cairo, Egypt
President: Dr. Gamal Shiha

APASL 2018 Annual Meeting in India

Date: March 15-18, 2018
City: New Delhi, India
President: Dr. Barjesh C. Sharma

APASL 2019 Annual Meeting in Philippines

Date: To be announced.
City: Manila, Philippines
President: Dr. Diana A. Payawal

APASL Guidelines

Now the APASL Guidelines have been published in Hepatology International as follows!!!

APASL Guidelines for HBV (Hepatol Int (2016) 10:1–98)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation on treatment of hepatitis C” (Hepatol Int DOI 10.1007/s12072-016-9717-6)

*This APASL Guideline can be downloaded by clicking below.

APASL Guidelines for HCV -”APASL consensus statements and recommendation for hepatitis C prevention, epidemiology, and laboratory testing” (Hepatol Int DOI 10.1007/s12072-016-9736-3)

*This APASL Guideline can be downloaded by clicking below.

  • APASL Guidelines for HCC (Hepatol Int 2010; 4: 439-474)
  • APASL Guidelines for Acute-on-chronic Liver Failure (Hepatol Int 2014; 8: 453-471)
  • APASL Guidelines for Fibrosis (Hepatol Int 2009; 3: 323-333)
  • APASL Guidelines for IPH (Hepatol Int 2007; 1: 398-413)
  • APASL Guidelines for Variceal Bleeding (Hepatol Int 2008; 2: 429-439)

APASL Fellowship 2017

The objective of the fellowship is to foster career development by encouraging the beneficial experience of working in a different clinical or research environment in another country in the Asia-Pacific region. These fellowships provide for advanced training in health and medical research in any country in the Asia-Pacific region and enable fellows to work in a clinical environment or on a research project with nominated advisers. We appreciate your generous contributions and support for these APASL fellowships and look forward to a number of high-quality applications for a 2017 fellowship.

An application form can be downloaded by clicking here: Please fill in and send to the APASL secretariat ( We are looking forward to receiving your application. There are no restrictions based on nationality. The sponsoring institution with the academic environment to provide adequate support for the proposed project might be suggested by APASL. Application will be reviewed by APASL Committee members. The decisions of the Committee are final and not subject to appeal.